The Effect of the Timing of Dexamethasone Administration in Patients with COVID-19 Pneumonia
Background Despite the proven benefits of dexamethasone in hospitalized coronavirus disease 2019 (COVID-19) patients, the optimum time for the administration of dexamethasone is unknown. We investigated the progression of COVID-19 pneumonia based on the timing of dexamethasone administration. Method...
Main Authors: | Hyun Woo Lee, Jimyung Park, Jung-Kyu Lee, Tae Yeon Park, Eun Young Heo |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2021-07-01
|
Series: | Tuberculosis and Respiratory Diseases |
Subjects: | |
Online Access: | http://e-trd.org/upload/pdf/trd-2021-0009.pdf |
Similar Items
-
Efficacy of awake prone positioning for severe illness coronavirus disease 2019 patients: a propensity score‐adjusted cohort study
by: Kenji Numata, et al.
Published: (2022-01-01) -
Dexamethasone as adjunctive therapy for treatment of varicella pneumonia
by: Mohamed A. Saraya, et al.
Published: (2012-07-01) -
Quantitative Computed Tomography Parameters in Coronavirus Disease 2019 Patients and Prediction of Respiratory Outcomes Using a Decision Tree
by: Jieun Kang, et al.
Published: (2022-05-01) -
The effectiveness of dexamethasone as a combination therapy for COVID-19
by: Namazi Nader
Published: (2022-09-01) -
Seroprevalence of severe acute respiratory syndrome coronavirus 2 immunoglobulin G antibodies among health-care workers prior and after 4–6 weeks of coronavirus disease vaccine administration at tertiary care center of southwest Bihar, India
by: Mukesh Kumar, et al.
Published: (2022-01-01)